Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $47600.0 on Feb 28 ’25. In the deal valued at $4.76 per share,10,000 shares were bought. As a result of this transaction, Polymeropoulos Mihael Hristos now holds 2,361,730 shares worth roughly $11.15 million.
Then, Polymeropoulos Mihael Hristos bought 10,000 shares, generating $47,600 in total proceeds. Upon buying the shares at $4.76, the President and CEO now owns 2,351,730 shares.
Before that, Polymeropoulos Mihael Hristos bought 10,000 shares. Vanda Pharmaceuticals Inc shares valued at $47,650 were divested by the President and CEO at a price of $4.76 per share. As a result of the transaction, Polymeropoulos Mihael Hristos now holds 2,341,730 shares, worth roughly $11.05 million.
H.C. Wainwright initiated its Vanda Pharmaceuticals Inc [VNDA] rating to a Buy in a research note published on October 31, 2024; the price target was $18. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid July with a ‘”an Overweight”‘ rating. Jefferies also remained covering VNDA and has decreased its forecast on February 25, 2022 with a “Hold” recommendation from previously “Buy” rating. BofA Securities started covering the stock on May 12, 2021. It rated VNDA as “a Buy”.
Price Performance Review of VNDA
On Monday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock fall -0.84% to $4.72. Over the last five days, the stock has gained 8.51%. Vanda Pharmaceuticals Inc shares have fallen nearly -1.46% since the year began. Nevertheless, the stocks have risen 5.59% over the past one year. While a 52-week high of $6.75 was reached on 01/02/25, a 52-week low of $3.71 was recorded on 02/14/25. SMA at 50 days reached $4.60, while 200 days put it at $5.06.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 4.59, which if violated will result in even more drops to 4.47. On the upside, there is a resistance level at 4.85. A further resistance level may holdings at 4.99. The Relative Strength Index (RSI) on the 14-day chart is 55.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 25.71%. Stochastics %K at 75.24% indicates the stock is a holding.
